Michael J Duffy (Michael Duffy)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Venues

Nutrition and cancer

Cancers

Breast cancer research and treatment

Medical oncology (Northwood, London, England)

Michael J Duffy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Michael J Duffy Jan 01 1990

Ireland

Professor :: Clinical Research Centre

Publications

Minhong Tang, John Crown, Michael J Duffy
Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells. Investigational new drugs (2023)
Michael J Duffy, John Crown
Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test? Critical reviews in clinical laboratory sciences (2023)
Michael J Duffy, Maeve Mullooly, Kathleen E Bennett, John Crown
Vitamin D Supplementation: Does It Have a Preventative or Therapeutic Role in Cancer? Nutrition and cancer 75 (2) (2022)
Michael J Duffy, Minhong Tang, Subhasree Rajaram, Shane O'Grady, John Crown
Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use? Cancers 14 (18) (2022)
Shane O'Grady, John Crown, Michael J Duffy
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells. Medical oncology (Northwood, London, England) 39 (10) (2022)
Michael J Duffy, Maeve Mullooly, Kathleen E Bennett, John Crown
Vitamin D Supplementation: Does It Have a Preventative or Therapeutic Role in Cancer? Nutrition and cancer 75 (2) (2022)
Michael J Duffy, Maeve Mullooly, Kathleen E Bennett, John Crown
Vitamin D Supplementation: Does It Have a Preventative or Therapeutic Role in Cancer? Nutrition and cancer (2022)
Michael J Duffy, John Crown
Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer. Journal of personalized medicine 12 (1) (2022)
Michael J Duffy, Maeve Mullooly, Kathleen E Bennett, John Crown
Vitamin D Supplementation: Does It Have a Preventative or Therapeutic Role in Cancer? Nutrition and cancer 75 (2) (2022)
Michael J Duffy, John Crown
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein Biomarkers. Clinical chemistry 68 (11) (2022)
Minhong Tang, Shane O'Grady, John Crown, Michael J Duffy
MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975. Breast cancer research and treatment 195 (2) (2022)
Denis Horgan, Gennaro Ciliberto, PierFranco Conte, Giuseppe Curigliano, Luis Seijo, Luis M Montuenga, Marina Garassino, Frederique Penault-Llorca, Fabrizia Galli, Isabelle L Ray-Coquard, Denis Querleu, Peter Riegman, Keith Kerr, Hein Van Poppel, Anders Bjartell, Giovanni Codacci-Pisanelli, Jasmina Koeva-Balabanova, Angelo Virgilio Paradiso, Zorana Maravic, Vassiliki Fotaki, Núria Malats, Chiara Bernini, Simonetta Buglioni, Alastair Kent, Elisabetta Munzone, Ivica Belina, Jan Van Meerbeeck, Michael J Duffy, Beata Jagielska, Ettore Capoluongo
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine. Cancers 13 (3) (2021)
Michael J Duffy, John Crown
Drugging "undruggable" genes for cancer treatment: Are we making progress? International journal of cancer 148 (1) (2020)
Naoise C Synnott, David O'Connell, John Crown, Michael J Duffy
COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells. Breast cancer research and treatment 179 (1) (2019)
Patricia Gaule, Nupur Mukherjee, Brendan Corkery, Alexander J Eustace, Kathy Gately, Sandra Roche, Robert O'Connor, Kenneth J O'Byrne, Naomi Walsh, Michael J Duffy, John Crown, Norma O'Donovan
Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells. Cancers 11 (4) (2019)
Michael J Duffy
Circulating tumour DNA as a cancer biomarker. Annals of clinical biochemistry 56 (1) (2018)
Michael J Duffy, Enda W McDermott, John Crown
Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 40 (5) (2018)

Michael J Duffy.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Duffy)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Duffy (Michael Duffy)